Time(s) and GFLOPs savings of single-agent tasks. by Hongjie Zhang (136127)

“…The inferences reduction significantly decreases the time and FLOPs required by the <i>LazyAct</i> algorithm to complete tasks. …”

The source code of LazyAct. by Hongjie Zhang (136127)

“…The inferences reduction significantly decreases the time and FLOPs required by the <i>LazyAct</i> algorithm to complete tasks. …”

Win rate vs Skip ratios on multi-agents tasks. by Hongjie Zhang (136127)

“…The inferences reduction significantly decreases the time and FLOPs required by the <i>LazyAct</i> algorithm to complete tasks. …”

Visualization on SMAC-25m based on <i>LazyAct</i>. by Hongjie Zhang (136127)

“…The inferences reduction significantly decreases the time and FLOPs required by the <i>LazyAct</i> algorithm to complete tasks. …”

Single agent and multi-agents tasks for <i>LazyAct</i>. by Hongjie Zhang (136127)

“…The inferences reduction significantly decreases the time and FLOPs required by the <i>LazyAct</i> algorithm to complete tasks. …”

Network architectures for multi-agents task. by Hongjie Zhang (136127)

“…The inferences reduction significantly decreases the time and FLOPs required by the <i>LazyAct</i> algorithm to complete tasks. …”

Immunogenicity results of different vaccination schemes at different time points. by Rima Moghnieh (679199)

Subjects:

Effectiveness of the available COVID-19 primary and booster vaccination schemes against laboratory-confirmed infections during the different waves. by Rima Moghnieh (679199)

Subjects:

Effectiveness of the available COVID-19 primary and booster vaccination schemes against acute-care hospitalization attributed to laboratory-confirmed infections during the differen... by Rima Moghnieh (679199)

Subjects:

Immunogenicity assessment groups based on the primary and booster vaccination schemes and timeframe from the second or booster dose. by Rima Moghnieh (679199)

Subjects:

Demographic and clinical characteristics of the participants used to estimate effectiveness of the different vaccination schemes during the Omicron BA.4/BA.5 variant wave. by Rima Moghnieh (679199)

Subjects:

Humoral immune responses to SARS-CoV-2 spike protein following various primary vaccination schemes and booster doses with Sinopharm or Pfizer vaccines among COVID-19-naïve particip... by Rima Moghnieh (679199)

Subjects:

Demographic and clinical characteristics of the participants used to estimate effectiveness of the different vaccination schemes during the Alpha variant wave. by Rima Moghnieh (679199)

Subjects:

Demographic and clinical characteristics of the participants used to estimate effectiveness of the different vaccination schemes during the Omicron BA.1/BA.2 variant wave. by Rima Moghnieh (679199)

Subjects:

Fig 4 - by Rima Moghnieh (679199)

Subjects:

Demographic and clinical characteristics of the participants used to estimate effectiveness of the different vaccination schemes during the Delta variant wave. by Rima Moghnieh (679199)

Subjects:

Demographic and clinical characteristics of the participants used to estimate effectiveness of the different vaccination schemes during the mixed Delta and Omicron variant wave. by Rima Moghnieh (679199)

Subjects:

COVID-19 in Lebanon: The daily number of COVID-19 cases throughout the waves of the pandemic in Lebanon and associated SARS-CoV-2 variants between January 2021 and September 2022. by Rima Moghnieh (679199)

Subjects:

Study profile. by Rima Moghnieh (679199)

Subjects:

Fig 3 - by Rima Moghnieh (679199)

Subjects: